Effects of a caspase and a calpain inhibitor on resting energy expenditures in normal and hypermetabolic rats: a pilot study
Language English Country Czech Republic Media print-electronic
Document type Journal Article
Grant support
T32 GM008750
NIGMS NIH HHS - United States
PubMed
27070748
PubMed Central
PMC5494968
DOI
10.33549/physiolres.933201
PII: 933201
Knihovny.cz E-resources
- MeSH
- Amino Acid Chloromethyl Ketones pharmacology therapeutic use MeSH
- Dipeptides pharmacology therapeutic use MeSH
- Energy Metabolism drug effects MeSH
- Cysteine Proteinase Inhibitors pharmacology therapeutic use MeSH
- Caspase Inhibitors pharmacology therapeutic use MeSH
- Metabolic Diseases drug therapy etiology MeSH
- Pilot Projects MeSH
- Burns complications MeSH
- Rats, Sprague-Dawley MeSH
- Drug Evaluation, Preclinical MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone MeSH Browser
- calpain inhibitor III MeSH Browser
- Amino Acid Chloromethyl Ketones MeSH
- Dipeptides MeSH
- Cysteine Proteinase Inhibitors MeSH
- Caspase Inhibitors MeSH
Several diseases induce hypermetabolism, which is characterized by increases in resting energy expenditures (REE) and whole body protein loss. Exaggerated protein degradation is thought to be the driving force underlying this response. The effects of caspase and calpain inhibitors on REE in physiological and hypermetabolic conditions, however, are unknown. Thus, we studied whether MDL28170 (calpain inhibitor) or z-VAD-fmk (caspase inhibitor) affect REE under physiological conditions and during hypermetabolism post-burn. Rats were treated five times weekly and observed for 6 weeks. Treatment was started 2 h (early) or 48 h (late) after burn. In normal rats, MDL28170 transiently increased REE to 130 % of normal during week 2-4. z-VAD-fmk reduced REE by 20-25 % throughout the observation period. Within 14 days after burns, REE increased to 130+/-5 %. Whereas MDL28170/early treatment did not affect REE, MDL28170/late transiently increased REE to 180+/-10 % of normal by week 4 post-burn. In contrast, with z-VAD-fmk/early REE remained between 90-110 % of normal post-burn. z-VAD-fmk/late did not affect burn-induced increases in REE. These data suggest that caspase cascades contribute to the development of hypermetabolism and that burn-induced hypermetabolism can be pharmacologically modulated. Our data point towards caspase cascades as possible therapeutic targets to attenuate hypermetabolism after burns, and possibly in other catabolic disease processes.
See more in PubMed
BIOLO G, FLEMING RY, MAGGI SP, NGUYEN TT, HERNDON DN, WOLFE RR. Inverse regulation of protein turnover and amino acid transport in skeletal muscle of hypercatabolic patients. J Clin Endocrinol Metab. 2002;87:3378–3384. PubMed
CARLSON DE, CIOFFI WG, JR, MASON AD, JR, MCMANUS WF, PRUITT BA., JR Resting energy expenditure in patients with thermal injuries. Surg Gynecol Obstet. 1992;174:270–276. PubMed
CHAO T, HERNDON DN, PORTER C, CHONDRONIKOLA M, CHAIDEMENOU A, ABDELRAHMAN DR, BOHANON FJ, ANDERSEN C, SIDOSSIS LS. Skeletal muscle protein breakdown remains elevated in pediatric burn survivors up to one-year post-injury. Shock. 2015;44:397–401. PubMed PMC
COHEN S, NATHAN JA, GOLDBERG AL. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov. 2015;14:58–74. PubMed
COSTELLI P, REFFO P, PENNA F, AUTELLI R, BONELLI G, BACCINO FM. Ca(2+)-dependent proteolysis in muscle wasting. Int J Biochem Cell Biol. 2005;37:2134–2146. PubMed
DEV R. The assessment and management of cancer cachexia: hypogonadism and hypermetabolism among supportive and palliative care patients. Curr Opin Support Palliat Care. 2014;8:279–285. PubMed
DUAN H, CHAI J, SHENG Z, YAO Y, YIN H, LIANG L, SHEN C, LIN J. Effect of burn injury on apoptosis and expression of apoptosis-related genes/proteins in skeletal muscles of rats. Apoptosis. 2009;14:52–65. PubMed
EQUILS O, MOFFATT-BLUE C, ISHIKAWA TO, SIMMONS CF, ILIEVSKI V, HIRSCH E. Pretreatment with pancaspase inhibitor (Z-VAD-FMK) delays but does not prevent intraperitoneal heat-killed group B Streptococcus-induced preterm delivery in a pregnant mouse model. Infect Dis Obstet Gynecol. 2009;2009:749432. PubMed PMC
GRACZYK PP. Caspase inhibitors as anti-inflammatory and antiapoptotic agents. Prog Med Chem. 2002;39:1–72. PubMed
JESCHKE MG, GAUGLITZ GG, KULP GA, FINNERTY CC, WILLIAMS FN, KRAFT R, SUMAN OE, MLCAK RP, HERNDON DN. Long-term persistance of the pathophysiologic response to severe burn injury. PLoS One. 2011;6:e21245. PubMed PMC
JONES LK. Resting energy expenditure in patients with thermal injuries. J Parenter Enteral Nutr. 1993;17:94–96. PubMed
KAWAMURA M, NAKAJIMA W, ISHIDA A, OHMURA A, MIURA S, TAKADA G. Calpain inhibitor MDL 28170 protects hypoxic-ischemic brain injury in neonatal rats by inhibition of both apoptosis and necrosis. Brain Res. 2005;1037:59–69. PubMed
LEE HY, KANEKI M, ANDREAS J, TOMPKINS RG, MARTYN JA. Novel mitochondria-targeted antioxidant peptide ameliorates burn-induced apoptosis and endoplasmic reticulum stress in the skeletal muscle of mice. Shock. 2011;36:580–585. PubMed PMC
LI PA, HOWLETT W, HE QP, MIYASHITA H, SIDDIQUI M, SHUAIB A. Postischemic treatment with calpain inhibitor MDL 28170 ameliorates brain damage in a gerbil model of global ischemia. Neurosci Lett. 1998;247:17–20. PubMed
MADEDDU C, MANTOVANI G, GRAMIGNANO G, MACCIO A. Advances in pharmacologic strategies for cancer cachexia. Expert Opin Pharmacother. 2015;16:2163–2177. PubMed
MATSUDA T, CLARK N, HARIYANI GD, BRYANT RS, HANUMADASS ML, KAGAN RJ. The effect of burn wound size on resting energy expenditure. J Trauma. 1987;27:115–118. PubMed
NEVIERE R, FAUVEL H, CHOPIN C, FORMSTECHER P, MARCHETTI P. Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med. 2001;163:218–225. PubMed
PASIAKOS SM, CARBONE JW. Assessment of skeletal muscle proteolysis and the regulatory response to nutrition and exercise. IUBMB Life. 2014;66:478–484. PubMed
PEREIRA C, MURPHY K, JESCHKE M, HERNDON DN. Post burn muscle wasting and the effects of treatments. Int J Biochem Cell Biol. 2005;37:1948–1961. PubMed
RODRIGUEZ I, MATSUURA K, ODY C, NAGATA S, VASSALLI P. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med. 1996;184:2067–2072. PubMed PMC
SMITH IJ, LECKER SH, HASSELGREN PO. Calpain activity and muscle wasting in sepsis. Am J Physiol Endocrinol Metab. 2008;295:E762–E771. PubMed PMC
TREDGET EE, YU YM. The metabolic effects of thermal injury. World J Surg. 1992;16:68–79. PubMed
VANA PG, LAPORTE HM, WONG YM, KENNEDY RH, GAMELLI RL, MAJETSCHAK M. Proteasome inhibition after burn injury. J Burn Care Res. 2015 in press. PubMed PMC
WOLFE RR. Review: acute versus chronic response to burn injury. Circ Shock. 1981;8:105–115. PubMed
WONG YM, LA PORTE HM, SZILAGYI A, BACH HH, KE-HE L, KENNEDY RH, GAMELLI RL, SHANKAR R, MAJETSCHAK M. Activities of nonlysosomal proteolytic systems in skeletal and cardiac muscle during burn-induced hypermetabolism. J Burn Care Res. 2014;35:319–327. PubMed PMC
YASUHARA S, PEREZ ME, KANAKUBO E, YASUHARA Y, SHIN YS, KANEKI M, FUJITA T, MARTYN JA. Skeletal muscle apoptosis after burns is associated with activation of proapoptotic signals. Am J Physiol Endocrinol Metab. 2000;279:E1114–E1121. PubMed
YU CG, GEDDES JW. Sustained calpain inhibition improves locomotor function and tissue sparing following contusive spinal cord injury. Neurochem Res. 2007;32:2046–2053. PubMed